Arbutus Biopharma Corp Liquidation Value
ABUS
Other
Cash & Equivalents
$18.01M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $18.01M
Total Obligations: -$6.75M
$11.26M
Per share: $0.06
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $18.01M
AR: $1.45M
Total Obligations: -$6.75M
$12.70M
Per share: $0.07
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $18.01M
AR: $1.45M
Inventory: $0
Total Obligations: -$6.75M
$12.70M
Per share: $0.07
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $11.26M | $0.06 |
| Liquid Liquidation Value | $12.70M | $0.07 |
| Operating Liquidation Value | $12.70M | $0.07 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $18.01M |
| Accounts Receivable | $1.45M |
| Inventory | N/A |
| Current Liabilities | $6.01M |
| Long-term Debt | $0 |
| Op. Lease Liability | $746,000 |
| Finance Lease | N/A |
| Shares Outstanding | 192.5M |
Explore all 140 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $18.01M | $1.45M | N/A | N/A | $6.01M | $0 | $746,000 | N/A |
| 2025-09-30 | $22.41M | $905,000 | N/A | N/A | $5.18M | $0 | $922,000 | N/A |
| 2025-06-30 | $37.41M | $1.02M | N/A | N/A | $5.02M | $0 | $1.09M | N/A |
| 2025-03-31 | $37.08M | $1.18M | N/A | N/A | $19.43M | $0 | $1.19M | N/A |
▼ Community Notes